It’s Elementary.

Slides:



Advertisements
Similar presentations
Validation of Mayo Clinic Risk Adjustment Model for In-Hospital Mortality following Percutaneous Coronary Interventions using the National Cardiovascular.
Advertisements

Absence of Flow-Limiting Coronary Artery Disease Among Patients Undergoing Emergent Cardiac Catheterization For ST Segment Elevation Myocardial Infarction.
Correlation between post-PTCA resolution of ST segment and mortality in STEMI patients First author: Diana Opincariu Co-authors: Carmen Moldovan Daniel.
Date of download: 6/23/2016 Copyright © The American College of Cardiology. All rights reserved. From: When to stress patients after coronary artery bypass.
Date of download: 7/5/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early Aldosterone Blockade in Acute Myocardial Infarction:
From: Contemporary Mortality Risk Prediction for Percutaneous Coronary Intervention: Results From 588,398 Procedures in the National Cardiovascular Data.
From: Contemporary Mortality Risk Prediction for Percutaneous Coronary Intervention: Results From 588,398 Procedures in the National Cardiovascular Data.
Date of download: 9/19/2016 Copyright © The American College of Cardiology. All rights reserved. From: Characteristics and Long-Term Outcomes of Percutaneous.
Arch Intern Med. 2007;167(1): doi: /archinte Figure Legend:
Figure 1 Patient flow chart.
Copyright © 2008 American Medical Association. All rights reserved.
Kirk N Garratt MSc MD FSCAI
The Hidden Cost of Underutilizing PCI for Chronic Total Occlusions
Fractional Flow Reserve Workshop
A Framework for Diagnosing and Treating CTEPH
Preventing Thrombotic Complications in ACS: State of the Art
New Guidelines to Prevent SCD: What You Need to Know
CathPCI-NCDR Registry Mortality (STEMI)
NOACs, AF, and PCI: What Do the Latest Data Suggest?
Achieving Long-Term Protection Post-MI
Preventing SCD With a WCD: Reviewing the Results of the VEST Trial
Addressing Patients at High Risk for SCA
Advances in Coronary Artery Disease: Moving Beyond Antiplatelet Therapy.
Unmet Needs in the Secondary Prevention in ACS
Patient Presentation Patient’s Changing Condition Multiple Considerations To Balance.
Antiplatelet Therapy Post-ACS: Bridging the CAD Continuum
Percutaneous Mechanical Circulatory Support Devices
Global Burden of VTE. Preventing Thrombosis During and Post-Hospitalization: New Paradigms in Clinical Care.
Panelists. One Size May Not Fit All: A New Aspirin Option for the High-Risk Patient.
Antiplatelet Therapy and Secondary Prevention
How Value-Based Healthcare Affects Your Practice
Program Goals. What Will the Emerging Basal Insulin Products Mean for My Diabetes Practice?
Heart Failure Prevention: Mission Impossible?
PAH Therapy Revisited.
Updates in Pulmonary Arterial Hypertension
Considerations for Percutaneous Coronary Intervention (PCI)
Treatment Options to Consider
European Heart Association Journal 2007 April
CV Risk Doesn't End in the Cath Lab
Compare-Acute Trial design: STEMI patients undergoing primary PCI were randomized to fractional flow reserve (FFR)-guided complete revascularization (n.
PrEP.
Examining the Latest Evidence in PAH
Remote Patient Management:
Five Things You Need to Know About Secondary Prevention Post-ACS
Date: Presenter: Ryan Chen
Translating the Latest and Greatest Advances in PAH Into Clinical Practice.
Figure 1 PCI strategies in patients with STEMI and multivessel disease
The Cardiologist's Mindset in the Management of Diabetes and Coronary Artery Disease: Today and Tomorrow.
CV Risk Doesn't End in the Cath Lab
Updates in Heart Failure:
Preventing Clinical Events in PAH
Identifying High-Risk AF Patients
Mancini JG, et al. Am J Cardiol.
LDL Cholesterol.
ACC/SCAI – i2 Summit Late Breaking Clinical Trials March 29, 2008
Challenges in LA SCCHN.
Factor Xa Inhibitors in Coronary Artery Disease
Improving Adherence to Antiplatelet Therapy After an ACS Event
Live on PAH: Breathing Life Into Patients With PAH
Antiplatelet Therapy Post-ACS: Bridging the CAD Continuum
Cardiology Fellow X Factor: An ACS Case of Therapeutic Challenges
Practical Tools for SCA Screening
OHSU – BDMS Heart CoE 2nd Video Conference June 19, 2018.
HF-Related Hospitalization and Readmissions
Pulmonary Arterial Hypertension and Hospitalizations
ESC Guideline on the Management of STEMI Recommendation for DAPT
My PAH Patient.
Propensity score-matching
The Power of As-Treated Analyses
Can the Dual vs Triple Therapy Controversy in Patients With AF Undergoing PCI Be Put to Rest?
Presentation transcript:

It’s Elementary

VALIANT High Early Risk of SCA

Patients With Low EF Following PCI

NCDR CathPCI® Registry Mortality (STEMI vs NSTEMI)

Case Presentation

Case Presentation

Hospital Course

Catheterization

Left Circumflex Artery Fractional Flow Reserve

Hospital Course

Final Angiogram After PCI

Post-PCI Care

CADILLAC Risk Score

Secondary Prevention Options

Cleveland Clinic Post-PCI Registry WCD Use Associated With Improved Survival

Adherence to WCD Use

WCD Benefits

Improving Adherence/Success

Abbreviations

Abbreviations (cont)

References

References (cont)

Thank you for participating in this activity.

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.